Trials / Completed
CompletedNCT00195741
The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents
Phase III, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Center Study Designed to Evaluate the Safety and Efficacy of Prophylactic Depakote ER in the Treatment of Adolescent Migraine
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Depakote ER is safe and effective in the reduction of occurrence of migraine headaches in adolescents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | divalproex sodium |
Timeline
- Start date
- 2003-05-01
- First posted
- 2005-09-20
- Last updated
- 2007-02-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00195741. Inclusion in this directory is not an endorsement.